There are other diabetes medications such as metformin and SGLT2 inhibitors that also aid in weight loss, Dr. Das points out.

It is estimated that more than 5.6 million people in the UK are living with diabetes, with 90 per cent suffering from type 2 ...

Analyzing electronic health records on 943,456 individuals with type 1 diabetes across 50 states, researchers found the ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. We are living in exciting ...

The connection between CVD and diabetes cannot be understated, as diabetes impacts CV health and heart conditions affect ...

As part of its ongoing RAK Diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the ...

New study reports protective effect among people with type 2 diabetes Kidney stones and the systemic conditions associated with them have a major impact on health and the economy in the US and ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.

Sotagliflozin is an oral dual sodium-glucose co-transporter types 1 and 2 (SGLT1/SGLT2) inhibitor. The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and ...